The estimated Net Worth of Joshua L Smiley is at least $51.4 Milion dollars as of 15 August 2024. Mr. Smiley owns over 15,900 units of Lilly(Eli) & Co stock worth over $43,819,630 and over the last 7 years he sold LLY stock worth over $237,600. In addition, he makes $7,348,400 as Chief Financial Officer a Senior Vice President at Lilly(Eli) & Co.
Joshua has made over 13 trades of the Lilly(Eli) & Co stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 15,900 units of LLY stock worth $14,642,151 on 15 August 2024.
The largest trade he's ever made was exercising 19,266 units of Lilly(Eli) & Co stock on 1 February 2021 worth over $17,741,867. On average, Joshua trades about 4,285 units every 117 days since 2018. As of 15 August 2024 he still owns at least 47,584 units of Lilly(Eli) & Co stock.
You can see the complete history of Mr. Smiley stock trades at the bottom of the page.
Joshua L. Smiley serves as Chief Financial Officer, Senior Vice President of the Company. He has served as senior vice president and treasurer of the company since October 2016. Mr. Smiley joined Lilly in 1995 as a financial analyst and has held a broad range of corporate strategy and financial management positions at the company. Before assuming his current position, he served as senior vice president and controller and chief financial officer of Lilly Research Laboratories from 2011 to 2016.
As the Chief Financial Officer a Senior Vice President of Lilly(Eli) & Co, the total compensation of Joshua Smiley at Lilly(Eli) & Co is $7,348,400. There are 1 executives at Lilly(Eli) & Co getting paid more, with David Ricks having the highest compensation of $21,283,200.
Joshua Smiley is 50, he's been the Chief Financial Officer a Senior Vice President of Lilly(Eli) & Co since 2018. There are 26 older and 4 younger executives at Lilly(Eli) & Co. The oldest executive at Lilly(Eli) & Co is Kathi Seifert, 71, who is the Independent Director.
Joshua's mailing address filed with the SEC is C/O ZAI LAB LIMITED, 314 MAIN STREET, 4TH FLOOR, SUITE 100, CAMBRIDGE, MA, 02142.
Over the last 20 years, insiders at Lilly(Eli) & Co have traded over $29,994,829,903 worth of Lilly(Eli) & Co stock and bought 73,808 units worth $5,778,435 . The most active insiders traders include Endowment Inc Lilly, R David Hoover a Lorenzo Tallarigo. On average, Lilly(Eli) & Co executives and independent directors trade stock every 7 days with the average trade being worth of $55,447,708. The most recent stock trade was executed by Endowment Inc Lilly on 3 September 2024, trading 24,084 units of LLY stock currently worth $23,281,762.
Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by, and named after, Colonel Eli Lilly, a pharmaceutical chemist and veteran of the American Civil War.
Lilly(Eli) & Co executives and other stock owners filed with the SEC include: